IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
IRIDEX CORP
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 18, 2026
$0.77−0.04 (-5.48%)
Close on Oct 19, 2026
- Market cap
- $13.41M
- P/E (TTM)
- –
- Dividend yield
- –
Iridex statistics
Financials through Jul 4, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Iridex | Industry median |
|---|---|---|
| Market Cap | $13.53M | $229.23M |
| Enterprise Value | $8.84M | $194.73M |
| PS Ratio | 0.26 | 3.14 |
| PB Ratio | 3.72 | 3.19 |
| P/TBV Ratio | 7.31 | 4.69 |
Enterprise value
| Measure | Iridex | Industry median |
|---|---|---|
| EV / Sales | 0.17 | 2.93 |
Income (trailing twelve months)
| Measure | Iridex | Industry median |
|---|---|---|
| Revenue | $51.57M | $102.39M |
| Gross Profit | $18.53M | $60.36M |
| Operating Income | -$2.78M | -$4.31M |
| Pretax Income | -$3.40M | -$2.26M |
| Net Income | -$3.55M | -$6.57M |
| EBITDA | -$2.33M | -$1.98M |
| EPS (Diluted) | -$0.20 | -$0.07 |
Margins
| Measure | Iridex | Industry median |
|---|---|---|
| Gross Margin | 35.9% | 55.1% |
| Operating Margin | -5.39% | -6.04% |
| Pretax Margin | -6.58% | -4.11% |
| Profit Margin | -6.88% | -10.5% |
| EBITDA Margin | -4.52% | -2.67% |
| FCF Margin | -3.88% | -0.30% |
Returns
| Measure | Iridex | Industry median |
|---|---|---|
| Return on Equity (ROE) | -73.1% | -19.2% |
| Return on Assets (ROA) | -12.1% | -13.3% |
| Return on Capital Employed (ROCE) | -19.7% | -9.07% |
Growth
| Measure | Iridex | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.68% | 8.85% |
| Revenue Growth (3Y CAGR) | -2.58% | 7.08% |
| Revenue Growth (5Y CAGR) | 7.70% | 11.8% |
Balance sheet
| Measure | Iridex | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.68M | $37.33M |
| Net Cash (Debt) | $4.68M | $3.92M |
| Net Cash Per Share | $0.27 | $0.28 |
| Equity (Book Value) | $3.64M | $57.36M |
| Book Value Per Share | $0.21 | $2.81 |
| Tangible Book Value | $1.85M | $10.71M |
| Working Capital | $10.79M | $54.64M |
Financial position
| Measure | Iridex | Industry median |
|---|---|---|
| Current Ratio | 1.82 | 2.50 |
| Quick Ratio | 0.79 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Iridex | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.73M | -$653.46K |
| Capital Expenditures | -$270.00K | -$3.69M |
| Free Cash Flow | -$2.00M | -$835.02K |
| FCF Per Share | -$0.11 | -$0.02 |
Efficiency
| Measure | Iridex | Industry median |
|---|---|---|
| Asset Turnover | 1.75 | 0.59 |
| Inventory Turnover | 3.63 | 2.21 |
| Revenue Per Employee | $554.55K | $322.75K |
| Profits Per Employee | -$38.14K | -$52.11K |
| Employee Count | 93 | 197 |
Dividends and yields
| Measure | Iridex | Industry median |
|---|---|---|
| Earnings Yield | -26.2% | -6.92% |
| FCF Yield | -14.8% | -0.62% |
Shares
| Measure | Iridex | Industry median |
|---|---|---|
| Shares Outstanding | 17,564,900 | 44,856,700 |
| Shares Change (YoY) | 3.31% | 3.35% |
| Shares Change (QoQ) | 0.33% | 0.27% |
| Float | 4,181,940 | 36,934,400 |
| Shares Held by Insiders | 76.2% | 10.6% |
| Shares Held by Institutions | 12.4% | 63.5% |
Taxes
| Measure | Iridex | Industry median |
|---|---|---|
| Income Tax | $152.00K | $1.52M |
Scores
| Measure | Iridex | Industry median |
|---|---|---|
| Altman Z-Score | -2.47 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.58 | -2.64 |
Calculated by StockData from Iridex's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.